ACTIV-3
Showing 1 - 25 of >10,000
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Insulin Resistance Trial in Baton Rouge (Exercise)
Completed
- Insulin Resistance
- Exercise
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 16, 2022
Myotonic Dystrophy 1 Trial in Jette (Low frequency repetitive stimulation)
Completed
- Myotonic Dystrophy 1
- Low frequency repetitive stimulation
-
Jette, Brussels Hoofdstedelijk Gewest, BelgiumUZ Brussel
Dec 21, 2022
Chronic Disease, Lumbago Trial in Brest (ACTIV'DOS group, Usual practise)
Recruiting
- Chronic Disease
- Lumbago
- ACTIV'DOS group
- Usual practise
-
Brest, Finistère, FranceCHRU de Brest
Dec 28, 2022
Coronary Artery Disease Trial (SIT LESS Booster)
Not yet recruiting
- Coronary Artery Disease
- SIT LESS Booster
- (no location specified)
Sep 7, 2023
Nutrition in People With a Lower Limb Amputation
Recruiting
- Diet, Food, and Nutrition
- +2 more
- No intervention
-
Scheemda, Groningen, Netherlands
- +4 more
Mar 1, 2023
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19, Chronic Heart Failure, Diabetes Trial in Moscow
Recruiting
- COVID-19
- +18 more
-
Moscow, Russian FederationEurasian Association of Therapists
Jul 30, 2022